Survivin expression in the bone marrow of patients with severe congenital neutropenia.
Carlsson
G
G
Boxhammer
S
S
Garwicz
D
D
Henter
J I
JI
Palmblad
J
J
Nordenskjöld
M
M
Porwit
A
A
Fadeel
B
B
D048868:Adaptor Proteins, Signal Transducing; D000293:Adolescent; D017209:Apoptosis; D001853:Bone Marrow / Q000378:metabolism* / Q000473:pathology; D002648:Child; D002675:Child, Preschool; D018450:Disease Progression; D005260:Female; D005786:Gene Expression Regulation / Q000187:drug effects; D016179:Granulocyte Colony-Stimulating Factor / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D051034:Inhibitor of Apoptosis Proteins; D051821:Lymphoid Enhancer-Binding Factor 1 / Q000502:physiology; D008297:Male; D008869:Microtubule-Associated Proteins / Q000096:biosynthesis* / Q000235:genetics; D022423:Myeloid Cells / Q000378:metabolism; D009503:Neutropenia / Q000151:congenital* / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D011506:Proteins / Q000235:genetics; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use; D012697:Serine Endopeptidases / Q000235:genetics; D000077022:Survivin; D055815:Young Adult
D048868:Adaptor Proteins, Signal Transducing; C107489:BIRC5 protein, human; C104759:HAX1 protein, human; D051034:Inhibitor of Apoptosis Proteins; C497573:LEF1 protein, human; D051821:Lymphoid Enhancer-Binding Factor 1; D008869:Microtubule-Associated Proteins; D011506:Proteins; D011994:Recombinant Proteins; D000077022:Survivin; D016179:Granulocyte Colony-Stimulating Factor; D012697:Serine Endopeptidases; C117309:pancreatic elastase II